TB Treatment Protocols and Guidelines

What is the initial dosage of Prednisolone for treating TB pericarditis?

Which treatment duration is recommended for bacteriologically confirmed TB pericarditis?

What is a key benefit of patient-centered directly observed therapy (DOT) for TB treatment?

What dosage of dexamethasone is recommended for treating TB meningitis?

What action should be taken for patients who miss treatment appointments?

What is the definition of multidrug resistant TB (MDRTB)?

Which baseline laboratory examination is recommended before starting anti TB treatment?

What is the classification of TB based on drug susceptibility involving resistance to one first line anti TB drug (excluding rifampicin)?

What individual is classified as a bacteriologically-confirmed patient with completed treatment?

Which group of patients should have baseline ALT and serum creatinine requested in resource-limited settings?

What is the minimum value for ALT in the presence of symptoms that necessitates stopping all medications immediately?

What is NOT recommended for screening for diabetes in TB patients according to the current guidelines?

When should medications be resumed for a patient whose sputum smear is positive after five months of treatment?

What is polydrug resistant TB defined as?

Which medication should be permanently discontinued if the patient is undergoing treatment?

Who should be offered counseling and testing for HIV when diagnosed with TB?

What condition qualifies a patient as clinically diagnosed but unable to have a sputum examination?

What is the classification for TB resistance that only includes resistance to one first line anti TB drug except rifampicin?

What is the first drug that may be restarted during a stepwise reintroduction of anti-TB drugs?

In which case should all medications be stopped immediately?

What should be offered to patients undergoing treatment as part of an incentive?

What should be done if a patient experiences a generalized erythematous rash along with fever or mucous membrane involvement while on TB medications?

Which TB medication is most likely to cause thrombocytopenia indicated by petechial rashes?

What is the recommended approach when re-challenging a patient with a previous drug sensitization?

What is the gold standard for diagnosing tuberculosis?

In the management of nephrotoxicity from TB medications, which of the following is NOT routinely required?

What duration of treatment is typically required for tuberculosis?

Which TB medication should be discontinued if a patient develops nephrotoxicity?

What symptoms should prompt further testing for nephrotoxicity in patients taking TB medications?

What should be monitored in all individuals receiving INH?

What is the recommended treatment to prevent INH induced neuropathy?

Which major adverse reaction requires discontinuing all drugs?

What is a common gastrointestinal symptom experienced during the initial weeks of treatment?

In case of visual impairment due to TB medications, testing should focus on changes in which areas?

Which of the following symptoms warrant a referral to an ENT specialist?

What is not necessary for liver function monitoring in asymptomatic patients on TB medications?

Which symptom is associated with positive identification of hyperuricemia in TB treatment?

What is recommended if a patient experiences prolonged gastrointestinal adverse drug reactions?

Managment of minor adverse reactions can involve which of the following?

Which of the following describes the effect of food intake on TB medications?

What is a minor adverse reaction that may occur with anti-TB drugs?

Which risk factor increases the likelihood of developing peripheral neuropathy when treated with INH?